Giving men a better chance of beating prostate cancer relies on a combination of early, accurate detection and advancements in personalised, less invasive treatments.
The Prostate Project, plays a crucial role in funding research, raising awareness, and providing resources to achieve these goals.
1. Advancements in Early Detection
Catching aggressive cancer when it is localised is the most critical factor for near-perfect survival rates (over 99%).
-
MRI-Targeted Biopsy: This standard-setting technique combines Magnetic Resonance Imaging (MRI) with real-time ultrasound during a biopsy. This allows doctors to precisely target suspicious areas, improving the detection of high-grade cancers while reducing unnecessary biopsies for harmless ones.
-
Genetic and Multi-Modal Screening: New large-scale trials (like the TRANSFORM trial in the UK) are comparing the effectiveness of PSA blood tests, genetic tests (which calculate risk based on DNA), and fast MRI scans. The goal is to establish a safer and more effective national screening program that avoids over-diagnosis while identifying dangerous cancers early.
-
Targeting High-Risk Groups: There is an urgent focus on improving outcomes for Black men, who are statistically twice as likely to get prostate cancer and twice as likely to die from it. Ensuring new screening methods are effective for this community is a priority in current research trials.
2. Targeted and Minimally Invasive Treatments
Treatment options are becoming more precise, focusing on killing cancer while preserving quality of life.
-
Focal Therapy: This approach, an alternative to whole-gland surgery or radiation, uses focused energy (like High-Intensity Focused Ultrasound (HIFU)) or electrical pulses to destroy only the cancerous areas within the prostate. This significantly reduces the risk of common side effects like incontinence and erectile dysfunction.
-
Theranostics: This cutting-edge field combines diagnosis and therapy. It uses molecules (like those targeting the PSMA protein on cancer cells) linked to both an imaging agent (to locate the cancer) and a radioactive substance (to destroy it), offering highly personalized treatment, especially for advanced disease.
-
PARP Inhibitors: These targeted drugs are approved for men whose cancers have specific gene mutations (like BRCA1/BRCA2). They work by blocking the cancer cells’ ability to repair their own DNA, causing the cells to die.
-
Robotic Surgery: Robotic radical prostatectomy enables surgeons to remove the prostate with extremely high precision through small incisions, leading to quicker recovery times and generally better functional outcomes.
3. The Role of The Prostate Project
The Prostate Project (prostate-project.org.uk) is a charity that aims to improve outcomes by funding research and providing essential support. Their key contributions include:
-
Funding Groundbreaking Research: The charity focuses on supporting research into early diagnosis and treatment. They are actively fundraising for projects such as a prostate cancer vaccine appeal to research developing a vaccine that could stop the cancer from returning.
-
Equipment Provision: They help make Surrey one of the world’s leading centers for urological cancer treatment by funding and providing state-of-the-art equipment at the Stokes Centre for Urology at Royal Surrey County Hospital in Guildford.
-
Awareness and Support: They run awareness initiatives like the “Man Van” (mobile clinic) and offer support services, including support groups, information on diet and exercise, and access to Clinical Nurse Specialist support.
For more information on the Prostate Project speak to Ian Blythe
